Your browser doesn't support javascript.
loading
The association of polypharmacy with COVID-19 outcomes independent of comorbidities in people with type 2 diabetes: implications for the unforeseen consequences of polypharmacy.
Gupta, Juhi K; Ravindrarajah, Rathi; Tilston, George; Ollier, Wiliam; Ashcroft, Darren M; Heald, Adrian H.
Afiliação
  • Gupta JK; Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, University of Manchester.
  • Ravindrarajah R; Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, University of Manchester.
  • Tilston G; Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, University of Manchester.
  • Ollier W; Faculty of Science and Engineering, Manchester Metropolitan University.
  • Ashcroft DM; Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester.
  • Heald AH; NIHR Greater Manchester Patient Safety Research Collaboration (PSRC), University of Manchester, Manchester.
Cardiovasc Endocrinol Metab ; 13(2): e0304, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38799205
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article